...
首页> 外文期刊>Muscle and Nerve >Prevalence and risk factors of muscle complications secondary to statins.
【24h】

Prevalence and risk factors of muscle complications secondary to statins.

机译:他汀类药物继发的肌肉并发症的患病率和危险因素。

获取原文
获取原文并翻译 | 示例

摘要

INTRODUCTION: The aim of the study was to investigate the prevalence and risk factors of muscle complications among patients using statins. METHODS: We conducted a prospective comparative study on 345 patients receiving statins and compared the findings with an age- and gender-matched control group of 85 subjects. Univariate and multivariate analyses with logistic regression models were used to study the association of different patient and disease characteristics with muscle complications. RESULTS: Adverse reactions were reported by 21% of patients and 5.9% of controls (P = 0.0013). Objective weakness was found in 15% of the patients who reported muscle symptoms (3.2% of the total cohort), but not in controls. Older age, longer duration of statin use, diabetes, stroke, and lower body mass index were associated with increased risk of developing these symptoms. CONCLUSIONS: Adverse reactions to statins may be more common than previously reported, and they may be affected by specific patient and disease characteristics.
机译:简介:本研究的目的是调查使用他汀类药物的患者中肌肉并发症的患病率和危险因素。方法:我们对345名接受他汀类药物的患者进行了一项前瞻性比较研究,并将结果与​​年龄和性别匹配的85名对照组进行了比较。使用具有逻辑回归模型的单变量和多变量分析来研究不同患者和疾病特征与肌肉并发症的关系。结果:21%的患者和5.9%的对照组报告了不良反应(P = 0.0013)。在报告肌肉症状的患者中有15%(占总队列的3.2%)发现了客观虚弱,但在对照组中没有发现。年龄较大,使用他汀类药物的持续时间较长,糖尿病,中风和较低的体重指数与发生这些症状的风险增加有关。结论:他汀类药物的不良反应可能比以前报道的更为普遍,并且可能受到特定患者和疾病特征的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号